AI-generated summary
This review examines how different light-based approaches, including green, blue, and bright light therapies, laser photobiomodulation, and optogenetics, may influence chronic pain pathways from molecular to circuit level. The authors report recent advances and translational progress in laser therapy and optogenetic neuromodulation, which they describe as promising for pain modulation. The abstract does not state specific effect sizes or patient outcomes.
- Who or what was studied
- chronic pain
- Limits stated in the abstract
- The abstract describes a narrative review and does not report the number of included studies, patient outcomes, or certainty of evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Neuromodulation, Laser, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.